By: Ludwig Cancer Research From: medicalxpress.com Cancer spreads (metastasizes) when tumor cells shed from a primary solid tumor (for example, in the breast) and embed in other organs, such as the lung, liver, and brain, and begin to grow. Most approaches to prevent this metastatic process aim to shrink or control the growth of the primary tumor. New research focused …
After 30 years of research, pill for breast cancer approved for use
By: Teddy Rosenbluth From: medicalxpress.com After six years of painful injections, Stephanie Walker has had enough. Every 28 days, she drives an hour to Duke’s Cancer center to get 50 mL slowly injected into her glute muscles. The viscous mixture of castor oil and medicine is painful going in and leaves lumps in its wake. Then she drives an hour …
Could a Cardiac Drug Stop Breast Cancer Metastasis?
By: Kara Baskin From: tufts.edu Triple-negative breast cancer is notoriously hard to treat. Assistant Professor Madeleine Oudin’s lab at the School of Engineering studies how to tame those cancer cells into submission. With Laidlaw Scholar Deepti Srinivasan, a senior biomedical engineering major and an aspiring physician, Oudin investigated how manipulating potassium channel activity could alter those cells’ bioelectric signals—making the cancer …
First CDK4/6 inhibitor OK’d for Early, High-Risk Breast Cancer
By: Mike Bassett From: medpagetoday.com Abemaciclib approved with endocrine therapy for hormone receptor-positive/HER2-negative disease The FDA approved the CDK4/6 inhibitor abemaciclib (Verzenio), in combination with standard adjuvant endocrine therapy, for certain patients with early breast cancer who are at high risk of recurrence, Eli Lilly announced. Indicated for patients who are node-positive and have hormone receptor-positive/HER2-negative disease, eligibility for the …
Jemperli
From: breastcancer.org Jemperli (chemical name: dostarlimab-gxly) is approved by the U.S. Food and Drug Administration (FDA) to treat mismatch repair deficient (dMMR) advanced-stage breast cancer that has grown during or after treatment if no other treatment options are available. Jemperli also is approved to treat dMMR advanced-stage endometrial cancer that has grown after treatment with platinum chemotherapy. How Jemperli works …
Breast Surgeons Demonstrate Accuracy of New Technology for Marking Location of Cancerous Lymph Nodes
Source: Hackensack Meridian Health From: trendkite.com Findings Also Make Procedure More Comfortable for Patients Breast surgeons at Hackensack Meridian Hackensack University Medical Center have a new tool that allows them to pinpoint breast tumors more easily, with many benefits to the patient. The reflector device has proven useful as an alternative to wire localization for locating breast tumors before lumpectomy. …
Many clinical trials for new cancer drugs didn’t include any data on race
By: Megan Thielking From: statnews.com One-third of the clinical trials that led to new cancer drugs approved between 2008 and 2018 didn’t report on the race of trial participants — and even studies that did report on race often had far fewer black and Hispanic cancer patients than might be expected, given the makeup of the cancer patient population.That’s according …
Home test a new option for colon cancer screening
From: cbsnews.com Colon cancer is the second leading cause of cancer deaths in the United States, but it doesn’t have to be. Now, a new, non-invasive home test for colon cancer will make screening more accessible to the millions of people who have avoided it. Colonoscopy is recommended once every 10 years for adults over the age of 50. However, …